APA (7th ed.) Citation

Nishimura, T., Fujiwara, T., Fujimoto, H., Tarumi, H., Tsuji, C., Iwanaka, S., . . . Ibata, H. (2023). Next‐generation sequencing clarified why first‐line treatment with osimertinib was ineffective in an autopsied case of EGFR‐mutated lung squamous cell carcinoma. Thoracic Cancer, 14(7), 709. https://doi.org/10.1111/1759-7714.14807

Chicago Style (17th ed.) Citation

Nishimura, Tadashi, et al. "Next‐generation Sequencing Clarified Why First‐line Treatment with Osimertinib Was Ineffective in an Autopsied Case of EGFR‐mutated Lung Squamous Cell Carcinoma." Thoracic Cancer 14, no. 7 (2023): 709. https://doi.org/10.1111/1759-7714.14807.

MLA (9th ed.) Citation

Nishimura, Tadashi, et al. "Next‐generation Sequencing Clarified Why First‐line Treatment with Osimertinib Was Ineffective in an Autopsied Case of EGFR‐mutated Lung Squamous Cell Carcinoma." Thoracic Cancer, vol. 14, no. 7, 2023, p. 709, https://doi.org/10.1111/1759-7714.14807.